MiR-429 suppresses neurotrophin-3 to alleviate perineural invasion of pancreatic cancer
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 505 (4) , 1077-1083
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology project of Shaanxi Province (2017SF-172)
- Central Universities (xjj2018131, 2014gjhz11)
- BIKANG (2017BIKANGJIJIN-020)
- Xi'an Jiaotong University for Young Scientists (YJ(QN)201305)
This publication has 20 references indexed in Scilit:
- Contemporary Management of Localized Resectable Pancreatic CancerCancers, 2018
- Epithelial-Mesenchymal Transition in Pancreatic Cancer: A ReviewBioMed Research International, 2017
- Pancreatic Cancer Chemoresistance to GemcitabineCancers, 2017
- Expression of Neurotrophin-3 and trkC following Focal Cerebral Ischemia in Adult Rat Brain with Treadmill ExerciseBioMed Research International, 2017
- The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cellsOncotarget, 2017
- PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic markerCellular and Molecular Life Sciences, 2017
- Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer CellsPLOS ONE, 2016
- MiR-429 Determines Poor Outcome and Inhibits Pancreatic Ductal Adenocarcinoma Growth by Targeting TBK1Cellular Physiology and Biochemistry, 2015
- Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancerOncotarget, 2014
- Clinical Significance of Carcinoma Invasion of the Extrapancreatic Nerve Plexus in Pancreatic CancerPancreas, 1996